Published in J Am Acad Dermatol on October 01, 1989
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol (2012) 1.79
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. Cancer Cell (2015) 1.70
Melanocyte transformation associated with substrate adhesion impediment. Neoplasia (2006) 1.06
Decoding melanoma metastasis. Cancers (Basel) (2010) 1.02
Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR. Mol Cancer (2006) 0.87
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma. Cancer Discov (2015) 0.86
Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. Am J Pathol (1994) 0.85
Nevomelanocytic proliferations and cutaneous malignant melanoma. J Am Acad Dermatol (1990) 0.75
Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid index. J Clin Pathol (2005) 0.75
Moles and melanoma--new method in the madness. West J Med (1994) 0.75
p15 Expression Differentiates Nevus from Melanoma. Am J Pathol (2016) 0.75
A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12
The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst (1996) 3.23
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
A factual, not arbitrary, basis for choice of resection margins in melanoma. Arch Dermatol (1996) 2.12
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol (1997) 2.02
A quantitative model of invasive Pseudomonas infection in burn injury. J Burn Care Rehabil (1994) 1.91
Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet (1999) 1.84
Spitz tumors in children: a grading system for risk stratification. Arch Dermatol (1999) 1.71
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Telogen skin contains an inhibitor of hair growth. Br J Dermatol (1990) 1.64
Ectodermal dysplasias associated with clefting: significance of scalp dermatitis. J Am Acad Dermatol (1992) 1.63
Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol (1990) 1.51
Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40
Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics (2001) 1.38
Leukemic vasculitis: a feature of leukemia cutis in some patients. Am J Clin Pathol (1997) 1.37
Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer (1995) 1.33
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol (1992) 1.29
Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer (1993) 1.27
Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest (1989) 1.22
The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest (1989) 1.22
Migrating epidermis produces AB2 collagen and requires continual collagen synthesis for movement. Nature (1979) 1.22
Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol (1998) 1.21
Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol (1991) 1.20
Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol (1982) 1.16
Desmoplastic melanoma. Histopathology (1992) 1.14
Mechanism of bovine prothrombin activation by an insoluble preparation of bovine factor X a (thrombokinase). Biochemistry (1972) 1.12
Sinonasal cancer and occupation: a case-control study. Am J Epidemiol (1980) 1.12
Epibolin: a protein of human plasma that supports epithelial cell movement. Proc Natl Acad Sci U S A (1981) 1.12
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol (1998) 1.11
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res (1996) 1.10
Multiple mechanisms of dissociated epidermal cell spreading. J Cell Biol (1983) 1.09
Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol (1993) 1.08
Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol (1996) 1.07
Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol (1998) 1.07
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol (1982) 1.07
Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer (1996) 1.05
Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol (1999) 1.04
Analysis of vascularity of human neurofibromas. J Am Acad Dermatol (1998) 1.03
Increased thickness of pregnancy-associated melanoma. Br J Dermatol (1995) 1.02
Changes in expression of apoptosis-associated genes in skin mark early catagen. J Invest Dermatol (1995) 1.01
Epidemiology of cancer of the nose and paranasal sinuses: current concepts. Head Neck Surg (1982) 1.01
Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99
Fibroblast-dependent induction of a murine skin lesion with similarity to human common blue nevus. Am J Pathol (1996) 0.99
Calcinosis cutis following extravasation of calcium chloride. Arch Dermatol (1988) 0.97
Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol (1993) 0.97
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol (2006) 0.96
Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer (1996) 0.95
Multiple primary cutaneous melanomas. Cancer (1992) 0.95
Validation of a melanoma prognostic model. Arch Dermatol (1998) 0.95
Oxidative stress, DNA repair, and cancer susceptibility. Cancer Detect Prev (1990) 0.94
Secular and age distribution of scrotal cancer in Connecticut and a review of United States literature. Cancer (1984) 0.94
What is the biological basis of pattern formation of skin lesions? Exp Dermatol (2006) 0.93
Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol (1993) 0.93
The Spitz tumor 50 years later: revisiting a landmark contribution and unresolved controversy. J Am Acad Dermatol (1999) 0.92
Time period compared to birth cohort in Connecticut incidence rates for twenty-five malignant neoplasms. J Natl Cancer Inst (1985) 0.92
Small cell sweat gland carcinoma in childhood. Am J Surg Pathol (1998) 0.92
Fibronectin (LETS) does not support epithelial cell spreading. J Invest Dermatol (1980) 0.92
Differential expression of the Hox 3.1 gene in adult mouse skin. Ann N Y Acad Sci (1991) 0.92
Scrotal carcinoma in Connecticut metalworkers: sequel to a study of sinonasal cancer. Am J Epidemiol (1982) 0.92
Primary malignant melanoma of the external auditory canal: a case report with presentation as an aural polyp. Am J Otol (1992) 0.91
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin. Lab Invest (1994) 0.90
Histologic spectrum of cutaneous involvement in patients with myelogenous leukemia including the neutrophilic dermatoses. Int J Dermatol (1995) 0.90
Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol (1997) 0.90
Malignant melanoma in situ: functional considerations of cancer. Hum Pathol (1990) 0.88
Prenatal diagnosis of Sjögren-Larsson syndrome. J Pediatr (1982) 0.88
Evaluation of factors associated with skin self-examination. Cancer Epidemiol Biomarkers Prev (1999) 0.87
Human serum and epithelial spread in tissue culture. Arch Dermatol Res (1979) 0.87
Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study. J Cutan Pathol (1993) 0.86
Spontaneous regression of cutaneous tumors. Adv Dermatol (1993) 0.86
Epithelial growth by rat vibrissae follicles in vitro requires mesenchymal contact via native extracellular matrix. J Invest Dermatol (1990) 0.86
C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay. Br J Dermatol (2007) 0.86
Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas. Eur J Cancer (2003) 0.86
Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: evidence for an amorphous matrix containing laminin. J Cutan Pathol (1999) 0.86
The role of serum in the epithelial outgrowth of mouse skin explants. Br J Dermatol (1978) 0.86
Proliferation of eccrine sweat ducts associated with alopecia areata. J Cutan Pathol (1988) 0.86
The epidermal pentapeptide pyroGlu-Glu-Asp-Ser-GlyOH inhibits murine hair growth in vivo and in vitro. Dermatologica (1991) 0.85
Vitronectin: effects on keratinocyte motility and inhibition of collagen-induced motility. J Invest Dermatol (1991) 0.85
Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol (1998) 0.85
The importance of elastic fibres in skin lymphatics. Br J Dermatol (1983) 0.85
Epidemiology of cutaneous melanoma. An update. Dermatol Clin (1991) 0.84
Transection level dictates the pattern of hair follicle sheath growth in vitro. Dev Biol (1994) 0.84
Melanoma and extravascular migratory metastasis. J Cutan Pathol (2000) 0.84
Malignant blue nevus. Case report and literature review. J Am Acad Dermatol (1988) 0.84
Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis. J Cutan Pathol (1999) 0.84
Abnormal nevi, excess total nevi, and melanoma: an epidemiologic perspective. Cancer Treat Res (1988) 0.84
The effects of hydrogen peroxide on DNA repair activities. Mutat Res (1995) 0.83
Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol (1995) 0.83
Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet (1994) 0.83
Dysplastic nevi in association with multiple primary melanoma. Cancer Res (1988) 0.83
Angiogenesis and regressing cutaneous malignant melanoma. Lancet (1992) 0.83
Metastasizing atypical fibroxanthoma. Coexistence with chronic lymphocytic leukemia. Arch Dermatol (1978) 0.83
Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis. Melanoma Res (2003) 0.82
Poly(ADP-ribose) polymerase in human breast cancer: a case-control analysis. Pharmacogenetics (1997) 0.82
Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas. J Immunol (1996) 0.82
Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI. Br J Cancer (1991) 0.82